Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Jan 20.
Published in final edited form as: Chem Commun (Camb). 2016 Jan 20;52(8):1737–1740. doi: 10.1039/c5cc10060g

Unified biogenesis of ambiguine, fischerindole, hapalindole and welwitindolinone: Identification of a monogeranylated indolenine as a cryptic common biosynthetic intermediate by an unusual magnesium-dependent aromatic prenyltransferase

Xinyu Liu a,*, Matthew L Hillwig a, Leonardus MI Koharudin b, Angela M Gronenborn b
PMCID: PMC4720564  NIHMSID: NIHMS750110  PMID: 26740122

Abstract

Biochemical characterizations of aromatic prenyltransferase AmbP1 and its close homologs WelP1/FidP1 in hapalindole-type alkaloid biosynthetic pathways are reported. These enzymes mediate the magnesium-dependent selective formation of 3-geranyl 3-isocyanovinyl indolenine (2) from cis-indolyl vinyl isonitrile and GPP. The role of magnesium cofactor in AmbP1/WelP1/FidP1 catalysis is highly unusual for a microbial aromatic prenyltransferase, as it not only facilitates the formation of 2 but also prevents its rearrangement to an isomeric 2-geranyl 3-isocyanovinyl indole (3). The discovery of 2 as a cryptically conserved common biosynthetic intermediate to all hapalindole-type alkaloids, suggests an enzyme-mediated Cope rearrangment and aza-Prins-type cyclization cascade is required to transform 2 to a polycyclic hapalindole-like scaffold.


Hapalindole-type alkaloids are a large group of indole monoterpenoids with broad-spectrum antimicrobial and antitumor activities that are exclusively produced by stigonematalean cyanobacteria.1 Their structural diversity and complexity constitutes a daunting puzzle that has provoked many intriguing biosynthetic proposals in the past three decades,2 whereas the underlying genetic, biochemical and molecular basis remained unknown until very recently.3

By strategic identification and comparative analysis of ambiguine (amb),3a welwitindolinone (wel)3b and fischerindole (fid)3c biosynthetic gene clusters in three distinct stigonematalean cyanobacteria that are able to generate all major structural phenotypes of hapalindole-type alkaloids, we recently provided compelling genetic and biochemical evidence that cis-indolyl vinyl isonitrile (Z)-1 and geranyl pyrophosphate (GPP) are the conserved common biosynthetic precursors to this family of natural products (Fig. 1).3a–c We also demonstrated that the chlorine substitution in hapalindole-type alkaloids is introduced by a new family of 2-oxoglutarate-dependent nonheme iron halogenase via late stage aliphatic C-H bond functionalization in the context of welwitindolinone biogenesis.3d

Figure 1.

Figure 1

Conserved intermediates identified in the early-stage biosynthesis of hapalindole-type alkaloids.

With the initial disclosure of amb gene cluster,3a we proposed the tri- or tetracyclic scaffolds in hapalindoles and fischerindoles may arise from a single step enzymatic unification between (Z)-1 and GPP by aromatic prenyltransferase AmbP1 that could act as a terpene cyclase.3a, 4 This enzymatic transformation would selectively define the stereochemistry of four consecutive carbon centers (C15, C10, C11, C12). This proposal implicates the stereochemical diversity across these four carbon centers in haplindole-type alkaloids from different producers would be due to the alterable stereochemical configuration of their precursors (i.e. (Z)-1 vs. (E)-1 and GPP vs. neryl pyrophosphate (NPP)). However, this proposal was readily disfavored after we identified the wel and fid gene clusters,3b–c which encode the identical set of genes for (Z)-1 and GPP assembly and do not have the capacity to biosynthesize (E)-1 and NPP. These observations led us to reformulate the role of AmbP1 and its close homologs WelP1 and FidP1 as a catalyst to transform (Z)-1 and GPP to a cryptic common intermediate,3b which can be subsequently enzymatically tailored to give structurally diverged hapalindole-type molecules (Fig. 1).

Here, we report the biochemical characterization of AmbP1 and its homologs WelP1/FidP1 and the structural elucidation of their enzymatic products from (Z)-1 and GPP. AmbP1 is shown to be an unusual aromatic prenyltransferase that can forward-transfer a geranyl group selectively to the C-3 carbon of (Z)-1 to give a monogeranylated indolenine 2. This enzymatic transformation strictly depends on the presence of Mg2+, highly unusual for microbial aromatic prenyltransferase.5 The identification of 2 as a cryptic intermediate, common to all hapalindole-type alkaloid biosynthetic pathways, suggests an enzyme-mediated sequential Cope rearrangement and aza-Prins-type cyclization cascade has to be in place for the stereoselective generation of tricyclic hapalindole scaffold as observed in 12-epi-hapalindole C.

To assess the biochemical function of AmbP1 and its homologs WelP1 and FidP1 from the wel and fid gene clusters (ESI, Fig. S1), they were overexpressed in E. coli and isolated as N-terminal His7-tagged fusion proteins (see ESI). Upon incubation of each protein with (Z)-1 and GPP with MgCl2 (5 mM) in Tris buffer (50 mM, pH=8.0), the rapid generation of two isomeric products 2 and 3 (both with m/z=305 [M+H]+) were observed by LC-MS analysis (Fig. 2a). The UV absorption spectra (190–350 nm) of products 2 and 3 do not match those of tri- or tetracylic hapalindoles or fischerindoles (ESI, Fig. S2). Instead, the UV absorption spectrum of 3 resembles that of (Z)-1, suggesting the presence of an intact indolyl vinyl isonitrile group, whereas the spectrum of 2 lacks distinct feature at 250–350nm, suggesting a de-aromatization of the indole ring (Fig. 2a). The enzymatic products derived from WelP1 and FidP1 are perfectly identical to that from AmbP1, confirming they are functionally identical that corroborates with the bioinformatic prediction as the sequences of WelP1 and FidP1 are 96% and 100% identical to AmbP1 (ESI, Fig. S1). In addition, (E)-1, the diastereomer of (Z)-1, is not a substrate for AmbP1, supporting our previous conclusion that (Z)-1 and GPP are the common biogenetic precursors to all hapalindole-type alkaloids,3b,f and ruling out the involvement of (E)-1 in their biogenesis as suggested by others.2a, 3e

Figure 2.

Figure 2

Initial characterization of AmbP1 and its homologs WelP1/FidP1 revealed Mg2+-dependent divergent enzymatic generation of monogeranylated indolenine 2 and indole 3 from (Z)-1 and GPP. a) Comparative HPLC chromatographs showing (Z)-1, but not (E)-1, is the substrate for AmbP1 and its homologs WelP1/FidP1, which can be converted to two products 2 and 3 in the presence of GPP with MgCl2 in Tris buffer (pH 8.0). b)-c) HPLC chromatographs showing the time course of AmbP1-mediated formation of 2 or 3 as the major enzymatic product from (Z)-1 and GPP in Tris buffer (pH 8.0) in the presence or absence of MgCl2. d) Selective formation of 2 or 3 from (Z)-1 and GPP by AmbP1 with MgCl2 at pH 9.0 or EDTA at pH 6.0.

As a mixture of 2 and 3 were generated in our initial assay, we proceeded with optimization to improve the selectivity. AmbP1 belongs to the ABBA aromatic prenyltransferase superfamily, of which a hallmark feature is that their enzymatic activities do not depend on the presence of divalent metal cations, such as Mg2+.5 However, an HPLC-based time course analysis of AmbP1 enzymatic activity at pH 8.0 clearly shows the presence of MgCl2 (5 mM) facilitates the generation of 2 and accelerates the turnover of (Z)-1, in comparison with the assays without MgCl2 (Fig. 3b–c). This unexpected observation suggests Mg2+ plays an important role in AmbP1 catalysis and prompted us to systematically examine the effect of Mg2+ concentration and pH on the outcome of this enzymatic transformation. We found with increased Mg2+ concentration (up to 20 mM) and pH (up to 9.0), 2 was preferentially formed (ESI, Fig. S3a–b), whereas the exclusion of Mg2+ and other divalent metal ion by the addition of EDTA (10 mM) at a decreased pH (up to 6.0) facilitates the formation of 3 (ESI, Fig. S3b–c), albeit slows down the enzymatic turnover of (Z)-1. With the optimized conditions for selective formation of 2 and 3 identified (Fig. 2d), the isolation of sub-mg of 2 and 3 were achieved by scaling up the enzymatic reaction. A combination of 1-D 1H and 2-D COSY, HSQC and HMBC NMR analyses (ESI, Fig. S4–11) allowed for the unambiguous structural assignment of 2 as 3-geranyl 3-isocyanovinyl indolenine (ESI, Table S1) and 3 as 2-geranyl 3-isocyanovinyl indole (ESI, Table S2). With the procurement of pure 2 and 3 as analytical standards, we were able to deduce the steady state kinetic parameters for AmbP-1 mediated enzymatic conversation of (Z)-1 to 2 and 3. At pH 8.0 with MgCl2 (10 mM), Km for (Z)-1 is 15.4±3.2 μM with a kcat of 6.9±1.2 s−1. The catalytic efficiency is in accordance with those of well-characterized microbial ABBA prenyltransferases.6 At pH 6.5 with EDTA (10 mM), the kcat of AmbP1 drops nearly 8-fold to 0.82±0.19 s−1, corroborating with our initial AmP1 time course analysis at different pH with or without Mg2+ (Fig. 2, ESI Fig. S3). Screening of other divalent metal ions (Ca2+, Zn2+, Mn2+) that can serve as alternatives for Mg2+ in ABBA prenyltransferases5b,c readily revealed Mg2+ cannot be replaced, as all of them either reduced or abolished the enzymatic activity of AmbP1 and are ineffective in mediating the selective formation of 2 from (Z)-1 (Fig. 3a). As 3,3-di-alkyl substituted indolenines are well known to undergo facile 1,2-alkyl shift to generate thermodynamically more stable 2,3-disubstitued indole under acidic conditions,7 we hypothesize that 3 is the shunt product from 2. At pH 6.5, the spontaneous rearrangement of 2 to 3 occurs with an estimated t1/2 of 6 h (ESI, Fig. S12). Intriguingly, the addition of AmbP1 at pH 6.5 in the presence of EDTA (10 mM) accelerates the rearrangement of 2 to 3 by at least 10-fold (Fig. 3b). This accelerated rearrangement however, was effectively suppressed to the basal level by the addition of MgCl2 (20 mM) (Fig. 3c). This observation implicates Mg2+ likely interacts with the indole-containing substrate in the AmbP1 active site and the Mg2+-dependency of AmbP1 is mechanistically distinct from other Mg2+-dependent prenyltransferases where the role of Mg2+ is for activating pyrophosphate as a Lewis acid.8

Figure 3.

Figure 3

Conversion of (Z)-1 and GPP to 2 is the preferred enzymatic outcome of AmbP1 that depends on the presence of Mg2+. 1) Comparative HPLC chromatographs showing Mg2+ is the only divalent metal ion cofactor that allows for the selective formation of 2 by AmbP1. 2) HPLC chromatographs showing the time course of conversion of 2 to 3 is facilitated by the presence of AmbP1 at pH 6.5 with EDTA (10 mM). 3) HPLC chromatographs showing the time course of AmbP1-mediated conversion of 2 to 3 at pH 6.5 is readily suppressed by the presence of MgCl2 (20 mM). 4) NMR analysis of AmbP1 provides biophysical evidence on its interaction with Mg2+. Superposition of the 2D 1H-15N HSQC spectra of AmbP1 in the absence (black) and presence of Mg2+ (green) at ~1:10 molar ratio of protein to Mg2+. Selected resonances that exhibit noticeable chemical shift changes are encircled in magenta ovals. Note that residues marked with magenta asterisks also experience chemical shift perturbations; however, the bound resonances are too broad for detection.

Collectively, the functional role of Mg2+ in AmbP1 catalysis can be summarized as two-fold: facilitating the selective formation of 2 and suppressing its rearrangement to 3. To gain direct insight on the interaction of Mg2+ with AmbP1 protein, we carried out a NMR titration experiment. Chemical shift mapping of interactions by NMR titration experiments is a sensitive and powerful approach to identify binding sites in a protein at the residue level.9 Upon complex formation, the ligand modifies the contact surface by either inducing a conformational change and/or altering the electronic environment of the nuclei that reside at the interface in the complex. We used 15N-labeled AmbP1 protein and recorded changes in the 2D 1H-15N HSQC spectrum in the absence (free) and in the presence of Mg2+ (Fig. 3d). A superposition of the free protein spectrum and the one in the presence of a 10 fold molar excess of Mg2+ identifies resonances affected by Mg2+ binding that are enclosed in magenta ovals or labelled with asterisks (Fig. 3d). Several resonances experience changes, either being shifted or broadened, clearly confirming that AmbP1 interacts with Mg2+.

Having disclosed AmbP1 as an unusual Mg2+-dependent aromatic prenyltransferase that can selectively geranylate C-3 position of (Z)-1 to give indolenine 2, we further examined its substrate scopes for prenyl donors and acceptors (Fig. 4). In addition to GPP, dimethylallyl pyrophosphate (DMAPP) can be also processed by AmbP1 when combined with (Z)-1 (Fig. 4a). Two enzymatic products 2a and 3a were detected, of which UV absorption spectra shared the same features of 2 and 3 (ESI, Fig. S13), suggesting they are structural homologs. While 3a is selectively formed at pH 6.0 with EDTA (10 mM) (Fig. 4a, trace 1), the formation of 2a was not selective at pH 9.0 with MgCl2 (20 mM) (Fig. 4a, trace 2), different from what was observed with GPP as a substrate, suggesting Mg2+-dependent enzymatic property of AmbP1 is GPP-specific. Corroborating with this observation, when DMAPP and GPP were used in 1:1 ratio with (Z)-1, GPP is selectively processed to either give 1 or 2 (Fig. 4a, traces 3–4), with only trace amount of 2a and 3a generated. We also tested NPP (the diastereomer of GPP) and farnesyl pyrophosphate (FPP) as substrates for AmbP1, but they were not processed when combined with (Z)-1 (ESI, Fig. S14). These observations provide convincing evidence that GPP is the authentic natural substrate for AmbP1.

Figure 4.

Figure 4

Evaluation of alternative pyrophosphate and indole substrates confirms AmbP1 is a C-3 indole prenyltransferase and prefers GPP as the prenyl donor. a) Comparative HPLC chromatographs showing AmbP1 can accept DMAPP as a prenyl donor, but prefers GPP. b) Comparative HPLC chromatographs showing AmbP1 can also process 4 and 5 with GPP to give 6.

Alternative prenyl acceptors, including indole 4 and indole-3-carboxaldehyde 5, were also processed by AmbP1 when combined with GPP. In both cases, 3-geranylated indole 6 was isolated as the sole enzymatic products (Fig. 4b) (ESI, Fig. S15–18 and Table S3), either at pH 6.0 with EDTA (10 mM) or pH 9.0 with MgCl2 (20 mM), providing additional evidence that the C-3 of indole serves as the default nucleophile for GPP with AmbP1. The selective generation of 6 from 5 by AmbP1 implicates an enzymatic sequence of C3-geranylation, followed by C3-deformylation, is likely operant. Interestingly, the enzymatic turnover of 4 or 5 to 6 appeared faster in the absence of Mg2+ (Fig. 4b, traces 1/3 versus 2/4), highlighting the unusual Mg2+–dependent feature of AmbP1 is highly specific to its native substrates (Z)-1 and GPP.

The discovery of 2 as the kinetically preferred enzymatic product of AmbP1 and its homologs WelP1/FidP1 from (Z)-1 and GPP, provides strong evidence that it is the conserved biosynthetic intermediates for all hapalindole-type alkaloids and raises the question how it can be transformed into the polycyclic hapalindole-like scaffold. Indolenine 2 contains a 1,5-diene group embedded between the proximal C=C bond of geranyl group and that of vinyl isontrile, a natural motif for a pericyclic reaction (Fig. 5). This [3,3]-sigmatropic Cope rearrangement will lead to the diastereoselective formation of an alternate 1,5-diene 2a, where the distal C=C bond in the geranyl group can serve as a nucleophile to trap the newly generated conjugated imine via an aza-Prins-type cyclization to give 12-epi-hapalindole C (7), which can be further enzymatically diversified to other hapalindole-type scaffolds (Fig. 5).

Figure 5.

Figure 5

Proposed enzymatic conversion of 2 to 7 via sequential Cope rearrangement and aza-Prins-type cyclization as a conserved biosynthetic step for the late-stage divergent generation of hapalindole-type alkaloids.

Recently, Li and coworkers have utilized 2a-type intermediates in the stereoselective preparation of hapalindole-type molecules,10 where they demonstrated 2a-type molecules are able to undergo aza-Prins-type cyclization to give 7-like molecules. The resulting substituents at C10 and C15 are stereoselectively placed in a trans-configuration as the reaction proceeds through an all-equatorial chair-like transition state, supporting the hypothesis outlined in Fig. 5. The rearrangement of 2 to 2a can be potentially facilitated by AmbP1 itself, as fungal ABBA-type indole prenyltransferases have been proposed to use Cope rearrangement as an alternative pathway for selective prenylation.11 We extensively examined conditions by combining 2 and AmbP1 with various exogenous factors, such metal ions, heats and lights, but none of these combinations led to the formation of 7 or related hapalindole-type molecules (data not shown), suggesting additional enzyme(s) will be required for this process. During the late-stage preparation of this manuscript, a separate report emerged that described the cell-lysate fraction of the amb producer Fischerella ambigua UTEX1903 can facilitate the conversion of 2 to 12-epi-hapalindole U, a constitutional isomer of 7 with identical stereochemistry at C10–12 and C15,12 which corroborates with the proposal outlined in Fig. 5. A previously annotated functionally unknown AmbU4 protein was cited as the main effector for the observed enzymatic rearrangement.12 As both amb and related wel and fid gene clusters encode multiple copies of ambU homologs with variable protein sequences (50–60% sequence identify),3a–c it remains to be elucidated on the true functional roles of these enzymes in directing the structural diversities in each hapalindole-type alkaloid producer originated from a single intermediate 2, characterized in this report.

In summary, this work featured the discovery of 2 as a cryptically conserved biosynthetic intermediate for all hapalindole-type molecules, assembled by a highly unusual Mg2+-dependent aromatic prenyltransferase AmbP1 (and its homologs WelP1 and FidP1). This disclosure implies a rare enzyme-mediated Cope rearrangement and aza-Prins cyclization cascade may be required as a key enzymatic step to diverge 2 into structurally distinct tri- or tetracyclic hapalindole/fischerindole scaffolds, and bring additional excitement into the investigation of hapalindole-type alkaloid biogenesis, which has proven to be a treasure trove of new enzymatic transformations.13

Supplementary Material

ESI

Acknowledgments

The authors acknowledge University of Pittsburgh (to X.L.), National Institute of Health (Grant# GM080642 to A.M.G.) for supporting this work and Dr. Qin Zhu for assistance in preparing figures used in this manuscript.

Footnotes

Electronic Supplementary Information (ESI) available: [experimental details and NMR spectral copies of 2, 3, 4]. See DOI: 10.1039/x0xx00000x

Notes and References

  • 1.Bhat V, Dave A, MacKay JA, Rawal VH. The Alkaloids: Chemistry and Biology. 2014;73:65–160. doi: 10.1016/B978-0-12-411565-1.00002-0. [DOI] [PubMed] [Google Scholar]
  • 2.a) Park A, Moore RE, Patterson GML. Tetrahedron Lett. 1992;33:3257–3260. [Google Scholar]; b) Stratmann K, Moore RE, Bonjouklian R, Deeter JB, Patterson GML, Shaffer S, Smith CD, Smitka TA. J Am Chem Soc. 1994;116:9935–9942. [Google Scholar]; c) Raveh A, Carmeli S. J Nat Prod. 2007;70:196–201. doi: 10.1021/np060495r. [DOI] [PubMed] [Google Scholar]; d) Richter JM, Ishihara Y, Masuda T, Whitefield BW, Llamas T, Pohjakallio A, Baran PS. J Am Chem Soc. 2008;130:17938–17954. doi: 10.1021/ja806981k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.a) Hillwig ML, Zhu Q, Liu X. ACS Chem Biol. 2014;9:372–377. doi: 10.1021/cb400681n. [DOI] [PubMed] [Google Scholar]; b) Hillwig ML, Fuhrman HA, Ittiamornkul K, Sevco TJ, Kwak DH, Liu X. ChemBioChem. 2014;15:665–669. doi: 10.1002/cbic.201300794. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Liu X, Hillwig ML, Zhu Q, Fuhrman HA, Sevco TJ. unpublished results. [Google Scholar]; d) Hillwig ML, Liu X. Nat Chem Biol. 2014;10:921–923. doi: 10.1038/nchembio.1625. [DOI] [PubMed] [Google Scholar]; e) Micallef ML, Sharma D, Bunn BM, Gerwick L, Viswanathan R, Moffitt MC. BMC Microbiol. 2014;14:213. doi: 10.1186/s12866-014-0213-7. [DOI] [PMC free article] [PubMed] [Google Scholar]; f) Ittiamornkul K, Zhu Q, Gkotsi DS, Smith DRM, Hillwig ML, Nightingale N, Goss RJM, Liu X. Chem Sci. 2015;6:6836–6840. doi: 10.1039/c5sc02919h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Baunach M, Franke J, Hertweck C. Angew Chem, Int Ed. 2015;54:2604–2626. doi: 10.1002/anie.201407883. [DOI] [PubMed] [Google Scholar]
  • 5.a) Tello M, Kuzuyama T, Heide L, Noel JP, Richard SB. Cell Mol Life Sci. 2008;65:1459–1463. doi: 10.1007/s00018-008-7579-3. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Steffan N, Grundmann A, Yin WB, Kremer A, Li SM. Curr Med Chem. 2009;16:218–231. doi: 10.2174/092986709787002772. [DOI] [PubMed] [Google Scholar]; c) Heide L. Curr Opin Chem Biol. 2009;13:171–179. doi: 10.1016/j.cbpa.2009.02.020. [DOI] [PubMed] [Google Scholar]
  • 6.a) Pojer F, Wemakor E, Kammerer B, Chen H, Walsh CT, Li SM, Heide L. Proc Natl Acad Sci U S A. 2003;100:2316–2321. doi: 10.1073/pnas.0337708100. [DOI] [PMC free article] [PubMed] [Google Scholar]; a) Saleh O, Gust B, Boll B, Fiedler HP, Heide L. J Biol Chem. 2009;284:14439–14447. doi: 10.1074/jbc.M901312200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Liu KG, Robichaud AJ, Lo JR, Mattes JF, Cai Y. Org Lett. 2006;8:5769–5771. doi: 10.1021/ol0623567. [DOI] [PubMed] [Google Scholar]
  • 8.Liang PH, Ko TP, Wang AH. Eur J Biochem. 2002;269:3339–3354. doi: 10.1046/j.1432-1033.2002.03014.x. [DOI] [PubMed] [Google Scholar]
  • 9.a) Qin J, Vinogradova O, Gronenborn AM. Methods Enzymol. 2001;339:377–389. doi: 10.1016/s0076-6879(01)39323-0. [DOI] [PubMed] [Google Scholar]; b) Zuiderweg ER. Biochemistry. 2002;41:1–7. doi: 10.1021/bi011870b. [DOI] [PubMed] [Google Scholar]
  • 10.Lu Z, Yang M, Chen P, Xiong X, Li A. Angew Chem Int Ed Engl. 2014;53:13840–13844. doi: 10.1002/anie.201406626. [DOI] [PubMed] [Google Scholar]
  • 11.a) Luk LY, Tanner ME. J Am Chem Soc. 2009;131:13932–13933. doi: 10.1021/ja906485u. [DOI] [PubMed] [Google Scholar]; b) Tanner ME. Nat Prod Rep. 2015;32:88–101. doi: 10.1039/c4np00099d. [DOI] [PubMed] [Google Scholar]
  • 12.Li S, Lowell AN, Yu F, Raveh A, Newmister SA, Bair N, Schaub JM, Williams RM, Sherman DH. J Am Chem Soc. 2015 doi: 10.1021/jacs.1025b10136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Liu X. 2nd European Conference on Natural Products; Frankfurt, Germany. Sep 07, 2015. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ESI

RESOURCES